Trends of thromboprophylaxis and complications after major lower limb orthopaedic surgeries in Korea: National Health Insurance Claim Data

被引:17
作者
Kim, Sunyoung [1 ]
Ahn, Hongyup [2 ]
Shin, Soon-ae [3 ]
Park, Jong-heon [3 ]
Won, Chang Won [1 ,4 ]
机构
[1] Kyung Hee Univ, Grad Sch, Dept Med, Seoul, South Korea
[2] Dongguk Univ, Dept Stat, Seoul, South Korea
[3] Natl Hlth Insurance Serv, Big Data Steering Dept, Wonju, South Korea
[4] Kyung Hee Univ, Dept Family Med, Coll Med, Seoul, South Korea
关键词
Anticoagulant drug; Guideline; Hip fracture; Haemorrhage; Venous thromboembolism; DEEP VENOUS THROMBOSIS; KNEE ARTHROPLASTY; THROMBOEMBOLISM; PREVENTION; RISK; GUIDELINES; HIP; RIVAROXABAN; ENOXAPARIN;
D O I
10.1016/j.thromres.2017.04.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In Western countries, prophylaxis for venous thromboembolism (VTE) following major lower limb orthopaedic surgeries is recommended. However, that has not been the case in Asian countries, where the reported incidence of postoperative VTE has been low. The present study examined trends in VTE prophylaxis prescriptions and related complications following major lower limb orthopaedic surgeries in South Korea. Design/Participants: Using claim data from the National Health Insurance Corporation, 263,664 patients aged 65 years or older who underwent major orthopaedic surgeries (total hip arthroplasty [THA], total knee arthroplasty [TKA], or hip fracture surgery [HFS]) between 2008 and 2012 were included. Result: The prescription rate for VTE prophylaxis has increased from 62.4% in 2008 to 75.4% in 2012 (P < 0.001). The prescription rate for new oral anticoagulants following THA and TKA has increased drastically since 2010, while that following HFS has not. Instead, prophylactic use of aspirin or low molecular weight heparin has increased in HFS cases. The rate of postoperative complications has significantly increased annually only in HFS: VTE (P = 0.018) and brain haemorrhage or gastrointestinal bleeding (P= 0.019). Conclusion: This result could suggest the need for more studies about the use of VTE prophylactic medicines following HFS. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:48 / 52
页数:5
相关论文
共 26 条
[1]   Korean Guidelines for the Prevention of Venous Thromboembolism [J].
Bang, Soo-Mee ;
Jang, Moon Ju ;
Oh, Doyeun ;
Kim, Yeo-Kyeoung ;
Kim, In Ho ;
Yoon, Sung-Soo ;
Yoon, Hwi-Joong ;
Kim, Chul-Soo ;
Park, Seonyang .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (11) :1553-1559
[2]   Venous thromboembolism [J].
Blann, AD ;
Lip, GYH .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7535) :215-219
[3]   Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents [J].
Crowther, Mark A. ;
Warkentin, Theodore E. .
BLOOD, 2008, 111 (10) :4871-4879
[4]   Prevention of VTE in Orthopedic Surgery Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].
Falck-Ytter, Yngve ;
Francis, Charles W. ;
Johanson, Norman A. ;
Curley, Catherine ;
Dahl, Ola E. ;
Schulman, Sam ;
Ortel, Thomas L. ;
Pauker, Stephen G. ;
Colwell, Clifford W., Jr. .
CHEST, 2012, 141 (02) :E278S-E325S
[5]   Prevention of venous thromboembolism [J].
Geerts, WH ;
Pineo, GF ;
Heit, JA ;
Bergqvist, D ;
Lassen, MR ;
Colwell, CW ;
Ray, JG .
CHEST, 2004, 126 (03) :338S-400S
[6]   Prevention of venous thromboembolism [J].
Geerts, William H. ;
Bergqvist, David ;
Pineo, Graham F. ;
Heit, John A. ;
Samama, Charles M. ;
Lassen, Michael R. ;
Colwell, Clifford W. .
CHEST, 2008, 133 (06) :381S-453S
[7]  
Gomez D., 2016, J ARTHROPLAST
[8]   Special Issue: Korean's Universal Health Care System [J].
Kim, Dong Soo .
SOCIAL WORK IN PUBLIC HEALTH, 2010, 25 (02) :125-126
[9]   Risk of pulmonary embolism and/or deep venous thrombosis in Asian/Americans [J].
Klatsky, AL ;
Armstrong, MA ;
Poggi, J .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (11) :1334-1337
[10]   Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban [J].
Kwong, Louis M. .
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2013, 5 :143-148